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Glycinergic inhibition plays a central role in the auditory brainstem circuitries involved
in sound localization and in the encoding of temporal action potential firing patterns.
Modulation of this inhibition has the potential to fine-tune information processing in
these networks. Here we show that nitric oxide (NO) signaling in the auditory brainstem
(where activity-dependent generation of NO is documented) modulates the strength of
inhibition by changing the chloride equilibrium potential. Recent evidence demonstrates
that large inhibitory postsynaptic currents (IPSCs) in neurons of the superior paraolivary
nucleus (SPN) are enhanced by a very low intracellular chloride concentration, generated
by the neuronal potassium chloride co-transporter (KCC2) expressed in the postsynaptic
neurons. Our data show that modulation by NO caused a 15mV depolarizing shift of
the IPSC reversal potential, reducing the strength of inhibition in SPN neurons, without
changing the threshold for action potential firing. Regulating inhibitory strength, through
cGMP-dependent changes in the efficacy of KCC2 in the target neuron provides a
postsynaptic mechanism for rapidly controlling the inhibitory drive, without altering the
timing or pattern of the afferent spike train. Therefore, this NO-mediated suppression of
KCC2 can modulate inhibition in one target nucleus (SPN), without influencing inhibitory
strength of other target nuclei (MSO, LSO) even though they are each receiving collaterals
from the same afferent nucleus (a projection from the medial nucleus of the trapezoid
body, MNTB).
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INTRODUCTION
The superior olivary complex (SOC) consists of groups of highly
specialized brainstem nuclei that compute various acoustic fea-
tures in sound location processing. Irrespective of the specific
task, such as detecting differences in interaural time (medial
superior olive; MSO), interaural intensity (lateral superior olive;
LSO), or processing transient temporal information (superior
paraolivary nucleus; SPN), glycinergic inhibition mediated by the
medial nucleus of the trapezoid body (MNTB) is a key com-
ponent of the afferent input to each of these nuclei (Grothe
et al., 2010; Johnston et al., 2010). Thus, the MNTB is the
major inhibitory hub within the SOC, with individual MNTB
neurons providing collateral projections to multiple, function-
ally diverse targets (Banks and Smith, 1992; Sommer et al.,
1993) where they serve fast and temporally precise inhibition,
similar to the role of fast spiking inhibitory interneurons in
other brain circuits (Bartos et al., 2002; Tepper et al., 2004).
This common source of afferent inhibition (the MNTB) raises
the question of what mechanisms are available to modulate
the synaptic responses of the individual postsynaptic targets
which serve differing roles in these diverse computational
functions.
One key parameter of inhibitory strength is the chloride elec-
trochemical gradient, which is the driving force for the hyper-
polarizing action of synaptic inhibition and is determined by
the intracellular chloride concentration. Early in development
the sodium-potassium-chloride co-transporter type 1 (NKCC1)
maintains a high intracellular chloride ([Cl−]i) concentration
in most neurons and hence Cl−-mediated synaptic events are
depolarizing (Cherubini et al., 2011; Friauf et al., 2011; but
see Balakrishnan et al., 2003 for an exception). It is postulated
that early in development, inhibitory synapses generate excita-
tory postsynaptic potentials (EPSPs) that act to stabilize synapse
formation, and that as neurons mature there is a switch to
expression of neuronal potassium chloride co-transporter type
2 (KCC2), driving a low [Cl−]i and supporting hyperpolarizing
IPSPs (Kandler and Gillespie, 2005). The trafficking, cell surface
expression and transport-activity of KCC2 are closely controlled
by neuronal activity (Fiumelli et al., 2005; Wake et al., 2007) with
increased KCC2 activity caused by protein oligomerization and
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changes in phosphorylation (Casula et al., 2001; Blaesse et al.,
2006; Chamma et al., 2012). As [Cl−]i declines, the driving force
favors influx of Cl− ions which strengthens IPSPs and synaptic
inhibition (Lohrke et al., 2005; Friauf et al., 2011; Ben-Ari et al.,
2012). In mature neurons, KCC2 can be down-regulated under
pathophysiological conditions, reducing the effectiveness of inhi-
bition and causing hyperexcitability (Wake et al., 2007; Hewitt
et al., 2009; Boulenguez et al., 2010). A variety of mechanisms
modulate KCC2 activity and it is unclear which messengers medi-
ate particular physiological responses, but one potential candidate
is nitric oxide (NO).
NO is a gaseous messenger molecule involved in the regula-
tion of synaptic transmission and neuronal function (Garthwaite,
2008). In neurons it is generated by neuronal nitric oxide syn-
thase (nNOS) (Garthwaite and Boulton, 1995). Local NO may
also reflect activity in blood vessels (from endothelial or eNOS) or
inducible NO synthase (iNOS), with increased NO being associ-
ated with inflammatory and neurodegenerative diseases (Steinert
et al., 2010; Nakamura et al., 2013) as well as following prolonged
synaptic activity (Brenman et al., 1996; Holscher, 1997; Steinert
et al., 2008, 2011). NO binds to its intracellular receptor, solu-
ble guanylyl cyclase (sGC) leading to raised intracellular cGMP,
which in turn interacts with multiple kinases and phosphatases
(Francis et al., 2010).
Given the evidence for activity-dependent NO generation
in neural cells (Garthwaite et al., 1988; Brenman et al., 1996;
Steinert et al., 2008) and expression of KCC2 and nNOS
in the SOC (Reuss and Riemann, 2000; Reuss et al., 2000;
Balakrishnan et al., 2003; Lohrke et al., 2005; Blaesse et al.,
2006) we asked if these signaling pathways might converge to
adjust MNTB-mediated inhibition to the needs of the postsy-
naptic target neurons during specific stimulus conditions. Our
results provide evidence that NO signaling can powerfully modu-
late the strength of inhibitory synaptic transmission by changing
the Cl− equilibrium potential via cGMP-dependent regulation
of KCC2.
MATERIALS AND METHODS
IN VITRO PREPARATIONS
All experimental procedures were approved by the Bavarian dis-
trict government and were done according to the European
Communities Council Directive (2010/63/EU). C57Bl6 mice and
Mongolian gerbils (Meriones unguiculatus) (P12–P21) were killed
by decapitation and coronal brainstem slices (200µm-thick) con-
taining the SOC were cut in a high sucrose, low-sodium artificial
cerebral spinal fluid (ACSF) at ∼0◦C. Slices were maintained in
a normal ACSF at 37◦C for 30–45min, after which they were
stored at room temperature (∼20◦C) in a continually recycling
slice-maintenance chamber. Composition of the normal ACSF
was (mM): NaCl 125, KCl 2.5, NaHCO3 26, glucose 10, NaH2PO4
1.25, sodium pyruvate 2, myo-inositol 3, CaCl2 2, MgCl2 1, and
ascorbic acid 0.5; pH was 7.4, bubbled with 95% O2, 5% CO2.
For the low-sodium ACSF, NaCl was replaced by 200mM sucrose,
and CaCl2 and MgCl2 concentrations were changed to 0.5 and
6mM, respectively. Experiments were conducted at physiological
temperature with the recording chamber being continuously per-
fused with ACSF at a rate of 1–2ml min−1. An inline feedback
temperature controller and heated stage were used to maintain
chamber temperature at 36± 1◦C (TC344B,Warner Instruments,
Hamden, CT, USA).
PATCH-CLAMP
Whole-cell patch-clamp and current-clamp recordings were
made from visually identified SOC neurons (Olympus BX51WI
microscope) using an EPC10/2 HEKA amplifier, sampling at
50 kHz and filtering at 10 kHz. Patch pipettes were pulled from
borosilicate glass capillaries (GC150F-7.5, OD: 1.5mm; Harvard
Apparatus, Edenbridge, UK) using a DMZ Universal puller
(Zeitz). Their resistance was ∼3.5M when filled with a patch
solution containing (mM): K-gluconate 97.5, KCl 32.5, HEPES
40, EGTA 5, MgCl2 1, Na2phosphocreatine 5, pH was adjusted to
7.2 with KOH. Stated voltages are corrected for a liquid junction
potential of −11mV. Whole-cell series resistances were compen-
sated by 50–80% and recordings in which the series resistance
changed more than 2–3M were omitted from analysis. Synaptic
currents were evoked by afferent fiber stimulation with a concen-
tric bipolar electrode (FHC) driven by voltage pulses generated
by the HEKA amplifier and post-amplified by a linear stim-
ulus isolator (Pulse Stimulator AM-2100). Glutamatergic cur-
rents were blocked (50µM D-AP5, 20µM DNQX), GABAergic
currents were blocked by 10µM SR95531 and glycinergic cur-
rents were confirmed by blockade with 1µM strychnine. The
NO was applied via the NO donor sodium nitroprusside (SNP;
100µM) which was prepared immediately before use. sGC
was blocked with 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one
(ODQ, 1µM).
IMMUNOCYTOCHEMISTRY
The brains of fourMongolian gerbils (Meriones unguiculatus) and
four C57Bl6 mice (both aged 2–3 month) were perfusion-fixed
with 4% paraformaldehyde, cryoprotected with 22.5% sucrose
overnight and shock frozen in CO2 snow. Coronal brainstem sec-
tions were cut with a cryostat (40µm thick; LEICA CM 3050S)
and collected in phosphate buffered saline 0.05M, pH 7.4 (PBS).
After washing, non-specific binding sites were saturated with a
blocking solution containing 1% BSA, 0.3% Triton X-100, and
0.1% saponin in PBS, for 1 h at room temperature and incu-
bated in the primary antibody mix (diluted in blocking solution)
for two nights at 4◦C. The specificity of the primary antibod-
ies used has been previously published for rodents and relevant
publications are indicated for the respective antibodies. The pri-
mary antibodies used were: [rabbit anti-KCC2 1:500, Millipore,
07-432 (Kopp-Scheinpflug et al., 2011)], guinea pig anti-GlyT2
[1:500 Millipore, AB1773 (Hassfurth et al., 2010)], mouse
monoclonal anti NOS-B1 [1:200, Sigma N2280 (Coote and
Rees, 2008)], chicken anti-Map2 [1:1000, Neuromics, CH22103
(Kapfer et al., 2002)]. Subsequently, the sections were washed and
incubated with the appropriate secondary antibodies: Alexa488
donkey anti-rabbit (1:300, Molecular Probes A21206), Cy3 don-
key anti-guinea pig (1:300, Chemicon AP193C), Alexa488 donkey
anti-mouse (1:300, Invitrogen A21202), Alexa 647 donkey-anti-
chicken (1:300, Dianova 115-605-205). For the NADPH-d stain-
ing, sections were processed as described by Vincent and Kimura
(1992).
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IMAGE ACQUISITION
To image the NADPH-d stain in bright-field microscopy and
to visualize immunohistochemical labeling, the sections were
viewed with a VS120 S1 microscope [Olympus BX61VST with
software dotSlide® (Olympus)]. For overviews in Figure 1A and
in enlarged images of the immunohistochemical labeling, con-
focal optical sections were acquired with a Leica TCS SP confo-
cal laser-scanning microscope (Leica Microsystems, Mannheim,
Germany) equipped with a Plan 10.0×/NA 0.40 and a Plan
63×/NA1.32 oil immersion objective. After stack acquisition and
Z chromatic shift correction between color channels, RGB stacks,
montages of RGB optical sections, and maximum-intensity
projections were assembled into tables using ImageJ (1.39q
Wayan Rasband, National Institutes of Health, USA) and Adobe
Photoshop CS6 (Adobe Systems, San Jose, CA) software; figure
images were arranged using CorelDRAW X6 (Corel Corporation,
Ottawa, Ontario, Canada).
MEASUREMENT OF KCC2 ACTIVITY
Human neuroblastoma SHSY-5Y cells were grown in DMEM
containing 10% fetal bovine serum at 37◦C in a humidified atmo-
sphere containing 5%CO2. Cells were seeded on 10mmglass cov-
erslips 48 h prior to the experiment. SHSY-5Y cells were loaded
with the pH sensitive fluorescent dye BCECF-AM (0.5µM,
12min. 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein
acetoxymethyl ester; TefLabs) in a Ringer’s solution (composi-
tion in mM: NaCl 120, MgCl 0.8, KCl 5.4, CaCl 1.8, HEPES 20,
glucose 15) containing 0.1% BSA. Coverslips were placed in a per-
fusion chamber and imaged using 440/470 nm excitation filters
and a bandpass emission filter at 535 nm (Chroma Technology)
as described before (Hershfinkel et al., 2009). To monitor KCC2
activity we used the NH4Cl/BCECF paradigm (Hershfinkel et al.,
2009). In absence of extracellular K+, NH4Cl (5mM) added to
the extracellular solution results in equilibrium between NH3 and
NH+4 . This is disrupted as NH3 rapidly diffuses through themem-
brane, bindsH+ within the cytoplasm and causes alkalinization of
the cells, which is detected by an increase in BCECF fluorescence
(Figure 5A). In the absence of K+, the remaining extracellular
NH+4 serves as a surrogate potassium ion and is transported into
the cell by KCC2 via reverse transport (Chorin et al., 2011). The
NH+4 influx changes the equilibrium between NH3 and NH
+
4
within the cells, releasing H+, and leading to acidification and
a decrease of BCECF fluorescence. The rate of acidification is
proportional to KCC2 activity, and blocking KCC2 in mature
neurons blocks this transport and the acidification, leading to
a prolonged alkalinization of the cells (Hershfinkel et al., 2009).
Baseline KCC2 activity in SHSY-5Y cells is low, so the cells were
initially incubated in low-osmolarity Ringer’s solution containing
only 100mMNaCl for 5min. Subsequently, baseline fluorescence
was achieved and NH4Cl (5mM) was added to the superfusion,
nominally K+-free, Ringer’s solution. The acidification rate, rep-
resenting KCC2 activity, was calculated for a minimum of 20
cells/coverslip in each experiment. Rates were averaged across
5–10 independent measurements. As indicated, SNP (300µM)
was added for 45min, at a concentration not toxic to these cells
(Wagle and Singh, 2000) in the presence or absence of ODQ
(1µM) or the cell permeable Zn2+ chelator N,N,N′,N′-tetrakis
(2-pyridalmethyl) ethylenediamine (TPEN, 10µM). Statistical
analyses were performed using analysis of variance with post-hoc
comparisons.
DATA ANALYSIS AND STATISTICAL METHODS
Data analysis was conducted with IgorPro 5.0 and custom writ-
ten macros were employed. Statistical analyses of the data were
performed with SigmaStat/SigmaPlot™ (SPSS Science, Chicago,
IL). Results are reported as mean ± s.e.m.; n being the num-
ber of neurons recorded from at least three different animals.
Statistical comparisons between different data sets were made
using unpaired Student’s t-test, while before and after compar-
isons were made by the paired Student’s t-test. Differences were
considered statistically significant at p < 0.05.
RESULTS
The neuronal glycine transporter type 2 (GlyT2) labels the
inhibitory synaptic terminals around the respective target neu-
rons, where it is responsible for the re-uptake of glycine from
the synaptic cleft. Thus, GlyT2 is a reliable marker for neuron
populations that receive strong glycinergic inputs. In the audi-
tory brainstem, GlyT2 labeled neurons in the LSO,MSO, and SPN
which all receive powerful inhibition from the MNTB (Figure 1).
The labeling pattern of all three structures is comparable between
mouse (Figure 1A) and gerbil (Figure 1B). The MSO is smaller
in mouse compared to gerbil, as is expected for an animal with a
small head and little low-frequency hearing. The immunohisto-
chemistry also shows that KCC2 is expressed postsynaptically in
the LSO,MSO and SPN of bothmouse and gerbil and this mirrors
the presynaptic labeling for GlyT2 (Figure 1 insets).
KCC2 ACTIVITY LEVELS DIFFER BETWEEN BRAINSTEM NUCLEI
It is not possible to determine the activity and effectiveness
of the KCC2 transporter in these different nuclei by measur-
ing protein expression alone. KCC2 activity was monitored by
measuring changes in the reversal potential of glycinergic synap-
tic currents evoked in response to electrical stimulation of the
MNTB (and pharmacologically isolated by blocking glutamater-
gic and GABAergic components with 50µM D-AP5, 20µM
DNQX, and 10µM SR95531, respectively). The reversal poten-
tials of the glycinergic currents, Eglycine, were measured before
(closed triangles in Figure 1C) and after blocking KCC2 activity
with furosemide (0.5mM; open circles in Figure 1C). In whole-
cell patch recording, dialysis of the intracellular solution with the
pipette solution enabled the introduction of a high intracellular
chloride concentration (34.5mM) that should maximize KCC2
activity in order to restore the usually low intracellular chloride
concentration in LSO, MSO, and SPN neurons (Lohrke et al.,
2005). The activity of KCC2 in these neurons is evident from the
deviation of the measured IPSC reversal potential from the cal-
culated reversal potential based on the internal and external chlo-
ride concentrations using the Nernst equation (Ecalc = −46mV;
dotted line in Figure 1E). More negative deviations from Ecalc
toward more hyperpolarized reversal potentials provide an esti-
mate for the activity of KCC2 that is driving this displacement.
Blocking KCC2 by bath application of furosemide (0.5mM) con-
sistently shifted Eglycine toward more positive voltages near the
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FIGURE 1 | KCC2 mirrors the expression of GlyT2 in the superior
olivary complex. Overview of mouse (A) and gerbil (B) SOC and enlarged
images of LSO, MSO, and SPN double-labeled for GlyT2 (red), and KCC2
(green). Scale bars: 200µm in overviews, 25µm in magnified images. (C)
Glycinergic IPSCs were evoked in a mouse SPN neuron by electrical
stimulation of the MNTB. The command potentials ranged from −120 to
−30mV in steps of 10mV. The IPSC reversal potential changed from
−90mV in control conditions (closed triangles in panel D) to −70mV after
the blockade of KCC2 (open circles in panel D) with furosemide. Stimulus
artifacts were removed for clarity. (D) Current-voltage relationship for the
IPSCs shown in (C). The parallel shift of the curves indicates a sole
change in reversal potential without changing the conductance. (E) IPSC
reversal potentials were depolarized after blockade of KCC2. The deviations
from the calculated reversal potential (black dotted line) are indicative of
KCC2 activity levels and suggest that KCC2 is most active in the mouse
SPN. The small black and grey horizontal lines represent the mean value of
the respective control and the furosemide data sets. ∗p ≤ 0.05, ∗∗p ≤ 0.01
and ∗∗∗p ≤ 0.001.
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calculated Nernst potential (Figure 1D). This shift was now mea-
sured for neurons in LSO, MSO and SPN in both mouse and
gerbil (Figure 1E). Though there was a significant depolarizing
shift in Eglycine for all three nuclei in both mouse and gerbil, the
largest andmost consistent shift in Eglycine was seen in the neurons
of mouse SPN (Table 1).
NITRIC OXIDE AS AN ADDITIONAL (VOLUME) TRANSMITTER IN
AUDITORY BRAINSTEM SIGNAL PROCESSING
MNTB neurons express nNOS and generate the messenger
molecule NO in an activity-dependent manner (Steinert et al.,
2008, 2011). Here we show that nNOS is expressed in MNTB and
SPN neurons of mice and gerbils (Figures 2A,B). Not all neurons
in the SPN seem to express nNOS, but since NO acts as a vol-
ume transmitter it can affect even the nNOS negative neurons.
Besides somatic nNOS staining, there is also a strong nNOS-
positive labeling of the neuropil of the SOC nuclei. NADPH, a
necessary coenzyme for the generation of NO has been used to
successfully label nNOS positive neuronal somata as well as their
axons (Luth et al., 1995; Reuss et al., 2000). Within the audi-
tory brainstem NADPH positive somata are labeled in the MNTB
and in the SPN (Figures 2C,D), corroborating the nNOS stain-
ing (Figures 2A,B). Similar to the nNOS staining there is heavily
labeled neuropil in the LSO, MSO, and also the SPN, suggesting
NO might be involved in local signal processing throughout the
auditory brainstem. Although the labeling appeared weaker in the
gerbil SOC this could reflect the lower specificity of the nNOS
antibody that is based on the mouse sequence.
NO SIGNALING SUPPRESSES KCC2 ACTIVITY IN A cGMP DEPENDENT
MANNER
Sustained synaptic stimulation causes generation of NO within
the SOC (Steinert et al., 2008, 2011). Here, endogenous NO
release was mimicked by bath application of the NO-donor
(SNP; 100µM) and its effect on KCC2 activity was measured.
Strong KCC2 activity drives the negative Eglycine (Lohrke et al.,
2005) in mature mammalian auditory brainstem neurons.
Within the nuclei of the SOC in mouse and gerbil, mouse SPN
neurons showed the largest deviation from calculated reversal
potential for glycine (Figure 1C), suggesting that KCC2 activity
is strongest in the SPN. Therefore, SPN neurons might support
an activity-dependent mechanism that allows down-regulation
of KCC2, but this seems to be less essential in the MSO and
LSO. To test this hypothesis, the effect of NO on KCC2 activity
in mouse LSO, MSO and SPN was measured before and during
the application of NO. NO did not affect KCC2 activity in
MSO or LSO neurons, but caused a depolarizing shift in Eglycine
from −83.7 ± 5.4mV to −67.3 ± 4.5mV (n = 10, p = 0.002;
Figures 3A–C), in the SPN consistent with suppression of KCC2.
The IPSC current-voltage relationship showed a parallel shift
(Figure 3B) and the glycinergic conductance did not change
significantly during the NO application (IPSGcontrol: 39.1 ±
9.1 nS; IPSGNO: 36.7 ± 8.5 nS; n = 10; P = 0.57). These results
indicate that there was no direct effect of NO signaling on the
glycine receptors nor was there a major influence on presynaptic
glycine release (Figure 3D).
The messenger molecule NO can mediate its action either
via s-nitrosylation of proteins or by generation of cGMP and
downstream activation of kinases or phosphatases (Figure 4A).
To test between these mechanisms, ODQ (1µM) was used
to specifically block sGC. Indeed, the presence of ODQ
in the bath resulted in stable Eglycine values even during
the additional application of the NO-donor (Figures 4B,C;
control-Eglycine:−73.0 ± 5.2mV; ODQ-Eglycine:−73.1 ± 5.6mV;
ODQ/NO-Eglycine:−69.5 ± 5.6mV; n = 10; P = 0.809; ANOVA)
suggesting that NO modulation of KCC2 is mediated via a
sGC/cGMP-dependent signaling. We also analyzed the ampli-
tudes during ODQ-conditioning and following perfusion of
ODQ/NO. The change in amplitude was only about 10 percent
and was not significant in ANOVA testing against the control
condition (ODQ: 11 ± 8%; ODQ/NO: 9 ± 8%; p = 0.17).
A direct test for NO regulation of KCC2, was achieved bymon-
itoring KCC2-dependent NH+4 transport in SHSY-5Y neuroblas-
toma cells, which express endogenous KCC2 (Chorin et al., 2011).
Using the NH4Cl paradigm, KCC2 activity is represented by acid-
ification following reversed activity of KCC2 that is inducing
NH+4 transport into the cells (see Materials and Methods). Under
control conditions, NH+4 -induced acidification rate of −1.7 ±
0.1 × 10−4F440/F470/s (n = 5), was monitored (Figure 5A).
Application of the NO-donor SNP (300µM) resulted in down-
regulation of KCC2 activity by about 2-fold to −0.80 ± 0.07 ×
10−4 F440/F470/s (n = 13; Figure 5B). This confirms that KCC2
activity is suppressed by NO (Figure 5B). In cortical neurons an
increase in the intracellular zinc concentration has been shown to
cause consistent KCC2-suppression (Hershfinkel et al., 2009). To
test for a change in intracellular Zn2+ in the present experiment,
a membrane permeable Zn2+ chelator (TPEN; 10µM) was used
to chelate intracellular Zn2+ prior to the application of SNP while
KCC2-dependent NH+4 -induced acidification rate was monitored
in the cells. Interestingly, chelating intracellular Zn2+ completely
Table 1 | Suppression of KCC2-activity measured as shift in Eglycine by 0.5mM furosemide across different nuclei and species.
Mouse Gerbil
LSO MSO SPN LSO MSO SPN
Control Eglycine −68.6 ± 8.7mV −75.8 ± 15.7mV −90.6 ± 8.6mV −62.9 ± 4.9mV −67.4 ± 12.4mV −58.1 ± 3.03mV
Furosemide Eglycine −51.0 ± 8.2mV −52.2 ± 15.4mV −54.5 ± 14.3mV −47.0 ± 13.7mV −49.0 ± 12.8mV −36.4 ± 5.4mV
 Eglycine 17.6mV 23.6mV 36.2mV 15.9mV 18.4mV 21.7mV
n 6 6 7 6 6 4
Significance p = 0.037 p = 0.025 p ≤ 0.001 p = 0.035 p = 0.018 p = 0.014
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FIGURE 2 | nNOS expression in SPN and MNTB of mouse and gerbil.
Double-staining of (A) mouse and (B) gerbil SOC for MAP2 (red) and
nNOS (green); insets show the respective high magnification images of
SPN and MNTB. Histochemical staining of NADPH-diaphorase activity in
the SOC of (C) mouse and (D) gerbil. High-magnification images of SPN
and MNTB neurons show NADPH-d positive neurons in both nuclei
confirming the nNOS staining. Scale bars: 200µm in overviews, 25µm in
magnified images.
blocked the effect of SNP (−1.7 ± 0.2 × 10−4 F440/F470/s;
n = 7), suggesting that increased concentrations of intracellular
Zn2+ are involved in the NO-dependent attenuation of KCC2
activity in the SHSY-5Y cells (Figure 5B). To determine whether
the increase in intracellular Zn2+ was caused by s-nitrosylation or
by sGC/cGMP mediated signaling, the sGC inhibitor 1µMODQ
was applied prior to and during the SNP and again the suppressive
effect of the SNP was reversed to−1.3 ± 0.1 × 10−4 F440/F470/s
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FIGURE 3 | Nitric oxide suppresses KCC2 activity. (A) Glycinergic IPSCs
were evoked in a mouse SPN neuron by electrical stimulation of the MNTB.
The command potentials ranged from −120 to −30mV in steps of 10mV.
The IPSC reversal potential changed from −80mV in control conditions
to −50mV after the modulation of KCC2 activity by NO signaling.
(B) Current–voltage relationship for the SPN-IPSCs shown in (A). The parallel
shift of the curves indicates a sole change in reversal potential without
changing the conductance. (C) Average data show a significant depolarizing
shift in IPSC reversal potential following NO application in the SPN, but not
in LSO or MSO. (D) The overall glycinergic conductance in SPN neurons is
unchanged by NO, indicating no change in the glycine receptor or the glycine
release to be involved. ∗∗p ≤ 0.01.
(n = 7), consistent with the hypothesis that the rise in [Zn2+]i
is downstream of sGC/cGMP/PKG in causing suppression of
KCC2 (Figure 5B). Both, ODQ and also TPEN prevented the
NO-mediated suppression of KCC2 (Figures 5A,B). If however,
furosemide was applied in addition to ODQ and TPEN, KCC2
activity was again reduced due to a direct interaction between
KCC2 and furosemide (Figures 5A,B).
NO SUPPRESSES IPSPs AND OFFSET FIRING WITHOUT CHANGING
INTRINSIC ACTION POTENTIAL THRESHOLD
NO mediated suppression of KCC2 reduces the IPSP-driven
membrane hyperpolarization from −80.1 ± 2.2mV to −68.6 ±
1.6mV (n = 7; p ≤ 0.001; Figure 6A). The typical offset/rebound
firing pattern of SPN neurons in response to sound requires the
evoked IPSPs to hyperpolarize the membrane potential to about
−80mV (Kopp-Scheinpflug et al., 2011). Following NO signal-
ing, inhibitory synaptic inputs will no longer generate rebound
firing (Figure 6B). The SPN firing response to MNTB-evoked
IPSP trains was compared in the presence of low (control) or high
NO (Figure 6B). In control conditions, the trace shows a burst
of offset action potentials at the end of the stimulus train, but
after raising NO in the test condition, only smaller IPSPs were
generated which did not trigger offset firing at the end of the train.
This NO-mediated change in SPN firing could reflect a change
in postsynaptic intrinsic excitability, as observed in the MNTB
(Steinert et al., 2008), so somatic injection of hyperpolarizing
and depolarizing currents were used (Figure 6C) to test neuronal
excitability. The mean rate-level functions measured under con-
trol conditions completely overlapped with that measured during
the raised NO condition, indicating that there was no signifi-
cant change in intrinsically evoked action potential firing. Action
potential number and current threshold were the same before
and during application of NO (Figures 6C–F). This result cor-
roborates the finding that NO-mediated suppression of KCC2 is
the mechanism mediating the change in the neuronal firing in
the SPN, rather than any direct action of NO on action potential
generation.
PHYSIOLOGICAL RELEVANCE: NO REDUCES GAP-DETECTION ABILITY
OF SPN NEURONS
SPN neurons receive a range of synaptic projections and express
a suite of voltage-gated ionic conductances that enable these
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FIGURE 4 | Nitrergic signaling acting on KCC2 is cGMP-dependent.
(A) Cartoon of possible intracellular signaling mechanisms by NO. (B)
Glycinergic IPSCs were evoked in a mouse SPN neuron by electrical
stimulation of the MNTB. The command potentials ranged from −120 to
−50mV in steps of 10mV. Blockade of sGC with ODQ prevents the
depolarizing shift of the reversal potential normally observed following NO
application. (C) Average data show that ODQ prevents the NO-mediated
depolarizing shift in Eglycine. There is no significant change between the
three conditions.
neurons to integrate their inputs and fire rebound action poten-
tials at the end of an IPSP train (Kopp-Scheinpflug et al.,
2011). This in turn allows computation of auditory gap-detection
(Kadner and Berrebi, 2008). We used a gap-detection paradigm
to explore how this physiological mechanism is influenced by
NO signaling. Gap-detection on a cellular level was determined
by current-clamp recording from SPN neurons during synap-
tic stimulation of the inhibitory inputs from the MNTB. Two
100Hz stimulus trains of 100ms duration each were separated by
gaps of 20, 30, 40, 50, or 60ms (each gap-protocol was repeated
10 times). At the gap, short-latency offset action potentials were
generated (Figure 7A) in the SPN neurons, with action poten-
tial numbers proportional to gap-duration (Figure 7C). In the
control condition (low-NO), all gaps evoked action potentials
and gaps of 20ms or longer were reliably detected with success
rates greater than 50%. However, following bath application of
NO, gap-detection thresholds increased, so that only longer gaps
FIGURE 5 | NO-mediated suppression of KCC2 requires intracellular
cGMP and Zinc. (A) KCC2 activity was monitored with the pH-sensitive
dye BCECF in SHSY-5Y cells that express endogenous KCC2. Cells were
incubated for 5min with K+ free extracellular solution, and the rate of
intracellular pH change following application of NH4Cl (5mM) was
monitored (see Materials and Methods). (A,B) Plots of NH+4 - mediated
acidification rates (mean ± s.e.m.) in control, treated with NO, NO+ODQ,
NO+TPEN, or ODQ+TPEN+furosemide. Significance was assessed using
a One-Way ANOVA. Ns are given in the bars. ∗∗∗p ≤ 0.001.
triggered action potentials (Figures 7B,C) and gap-detection for
durations shorter than 60ms was disabled (Figure 7D).
DISCUSSION
The MNTB is a common source of glycinergic inhibition, but
this innervation is performing different functions in each of the
target nuclei. Given that individual MNTB neurons are pro-
jecting to multiple nuclei and firing patterns are the same for
each target, it is important to understand how the inhibitory
synaptic strength can be independently modulated in each tar-
get nucleus to fine-tune local synaptic actions. Conventionally
two options are considered: presynaptic modulation of trans-
mitter release and postsynaptic modulation of receptor acti-
vation and/or receptor kinetics. Here we demonstrate a third
option—namely modulation of the IPSC reversal potential. Our
results show that the gaseous messenger molecule NO can serve
as a control device of inhibitory synaptic strength by control-
ling ECl/Eglycine in the postsynaptic target neurons via cGMP-
dependent suppression of the potassium-chloride co-transporter
type 2 (KCC2).
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FIGURE 6 | NO suppresses IPSPs and offset firing without changing
intrinsic action potential threshold. (A) Suppression of KCC2 causes
synaptically-evoked IPSPs to be less hyperpolarizing. The grey bar indicates
the voltage threshold for generating rebound action potentials
(−80.4 ± 1.5mV; n = 71). (B) Glycinergic IPSPs in response to 100Hz pulse
trains (indicated by the mark below the recordings) evoked rebound action
potentials at the end of the train in the control condition (upper trace).
Application of NO (lower trace) reduced the IPSP amplitudes and did not
result in rebound firing. Stimulus artifacts were removed for clarity. (C)
Current-clamp responses to hyperpolarizing and depolarizing current
injections revealed similar firing patterns in the control and (D) the NO
condition. (E) Input–output functions did not differ between control and NO
conditions. (F) Injection of similar magnitude currents evoked similar
rebound firing (or firing in response to depolarization) for both conditions,
indicating no significant change in action potential threshold. ∗∗p ≤ 0.01.
KCC2 drives a low internal chloride concentration, hence
increasing the hyperpolarizing action of inhibition. KCC2 is
present throughout the central nervous system, but is particularly
highly expressed in the hippocampus, hypothalamus, brainstem,
and motor neurons of the spinal cord (Vinay and Jean-Xavier,
2008; Blaesse et al., 2009). Developmental up-regulation of KCC2
expression strengthens hyperpolarizing inhibition (Cherubini
FIGURE 7 | Nitric oxide suppresses gap-detection on a cellular level.
(A) Mouse SPN neurons show offset firing in responses to gaps of different
durations (60–20ms) embedded in trains of electrically evoked IPSPs. (B)
Bath application of an NO donor reduced the number of action potentials
per gap and delayed the action potential within the gap so that only longer
gaps were detected. Stimulus artifacts were removed for clarity. (C) The
number of evoked action potentials increased with gap duration in controls
(black bars), but was never more than one with NO (white bars). (D)
Repetitive stimulation (10 IPSP trains) was used to estimate gap-detection
success, which is plotted here as % offset action potentials against gap
duration. Threshold was defined as 50% success (dashed line); controls
(black) reliably detected gaps of 20ms or longer, but following NO,
gap-detection thresholds increased to 60ms or longer. Data plotted as
mean ± s.e.m. (n indicated on the respective graph).
et al., 2011; Friauf et al., 2011). Consequently, acquired loss of
KCC2 function in mature neurons will lead to hyperexcitabil-
ity and seizures due to less hyperpolarizing inhibitory inputs
(Wake et al., 2007; Vinay and Jean-Xavier, 2008; Boulenguez et al.,
2010; Arion and Lewis, 2011). Deficient KCC2 activity has been
described following neuronal damage such as physical trauma
or ischemia and the following mechanisms are suggested to be
involved: transcriptional regulation via neurotrophin receptor
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activation (Rivera et al., 2002, 2004), post-translational regula-
tion via changes in the phosphorylation state of KCC2 (Blaesse
et al., 2009; Chamma et al., 2013) and activity-dependent down-
regulation after NMDA-receptor activation and calcium influx
(Ginsberg, 2008; Lee et al., 2011). Previous experiments in the
auditory brainstem show that activation of NMDA receptors in
the MNTB causes the necessary calcium influx that triggers the
activation of nNOS and thus the generation of NO (Steinert
et al., 2008). As a volume transmitter NO can then act on the
surrounding neurons of LSO, MSO, and SPN. The SPN itself
also expresses nNOS [Figure 2; (Reuss, 1998; Reuss et al., 2000)],
providing a further local source of NO in the SPN. Here, we stud-
ied the link between NO and the mechanism by which KCC2 is
down-regulated. Our present data show that NO-mediated KCC2
suppression is absent if sGC is blocked, suggesting that KCC is
suppressed via a cGMP-dependent mechanism (Figure 4). An
additional possible downstream mechanism is the NO-mediated
recruitment of intracellular Zn2+ that suppresses KCC2 activity
(Hershfinkel et al., 2009). NO can trigger increase in [Zn2+]i in at
least two different ways; either via cGMP/PKG-dependent release
from internal stores (Jang et al., 2007) or via s-nitrosylation of
metallothioneins (Zhang et al., 2004). Our ODQ-data support
the NO-cGMP pathway leading to Zn2+-mediated suppression
of KCC2.
In the central nervous system NO is generally thought to
act as a retrograde volume transmitter that modulates transmit-
ter release presynaptically (for a recent reviews see Hardingham
et al., 2013). Here we show a postsynaptic mechanism which
mediates a parallel shift in the IPSC current-voltage relation-
ship that is inconsistent with a presynaptic change in transmitter
release. Instead we demonstrate that this regulation in inhibitory
strength is mediated by modulation of the chloride equilibrium
potential and does not involve the glycine receptors directly. It
is interesting to note that this mechanism is likely to be unique
to inhibitory synaptic transmission, since changing the sodium
or potassium equilibrium potential would interfere with action
potential generation, propagation and waveform.
SIGNIFICANCE OF KCC2 SUPPRESSION FOR INFORMATION
PROCESSING IN THE SPN
The present study employs amousemodel for in vitro demonstra-
tion of NO-mediated regulation of sound offset encoding/gap-
detection mechanisms in the auditory brainstem. Brief gaps
in sound determine sound rhythms (Felix et al., 2011; Kopp-
Scheinpflug et al., 2011) and suggest a correlation between gap-
detection and speech perception (Snell et al., 2002; Frisina et al.,
2006). Although information about sound offsets and gaps is pro-
cessed in the auditory cortex, it is derived from subcortical com-
putations (Scholl et al., 2010). Gaps in sound are reliably encoded
in the SPN in the auditory brainstem (Kadner and Berrebi, 2008;
Kopp-Scheinpflug et al., 2011) by a mechanism that requires
three elements: large glycinergic IPSPs, driven by an extreme
negative chloride reversal potential (ECl), combined with a large
hyperpolarization-activated non-specific cationic current (IH),
and a T-type calcium conductance (ITCa) (Kopp-Scheinpflug
et al., 2011). Our present data show that NO negatively modu-
lates KCC2 which can lead to the following cascade of events: less
hyperpolarized IPSPs cause less activation of IH (HCN channels)
and do not provide sufficient hyperpolarization to enable recov-
ery of ITCa (low-threshold calcium channels) from inactivation;
therefore the typical offset firing/gap detection in SPN neurons is
restricted by NO. The loss of temporal resolution (as measured
by gap-detection) is a prevalent dilemma in models of ageing,
hearing loss and neurodegeneration. At the same time individu-
als with inflammatory and neurodegenerative diseases often show
increased levels of NO in nervous system tissue (Sweeten et al.,
2004; Steinert et al., 2010). Effective modulators of gap-detection
thresholds would provide an important mechanism which would
influence higher levels of processing. Attempts to improve gap-
detection by facilitating GABAergic inhibition have failed (Gleich
and Strutz, 2011) which is consistent with the glycinergic/KCC2
mechanism as described here. Facilitation of KCC2 (e.g., by NO-
scavengers) could be considered for future treatments as a means
to enhance local inhibition in the brain.
SIGNIFICANCE OF KCC2 SUPPRESSION FOR BINAURAL INFORMATION
PROCESSING IN THE MSO AND LSO
In both, the interaural level difference processing LSO as well as
in the interaural time difference processing MSO, the balance of
excitation andMNTB-mediated inhibition is crucial for adjusting
the binaural sensitivity of single neurons as well as the popu-
lation output (Grothe et al., 2010). Traditionally considered to
be rather static, the binaural sensitivity of both, LSO and MSO,
has recently been shown to be surprisingly dynamic (Magnusson
et al., 2008; Hassfurth et al., 2010; Fischl et al., 2012; Stange et al.,
2013). Modulation via NO may superimpose these adaptations
on the binaural system by globally adjusting synaptic sensitiv-
ity to changing levels of acoustic exposure. However, according
to our present study, NO-mediated suppression of KCC2 activ-
ity results in a weakening of the main inhibitory input to SPN
neurons. In contrast, KCC2 activity in LSO and MSO neurons is
not affected, suggesting a different role of NO than suppressing
inhibition.
In summary, our results show that the NO synthesizing
enzyme nNOS is expressed in the SOC where NO can be gener-
ated in an activity-dependent manner. Future studies should aim
at identifying the significance of NO as a volume transmitter in
the auditory brainstem in an in vivo preparation. NO can act as
a powerful modulator of inhibitory transmission by suppressing
KCC2. This novel mechanism of activity-dependent modulation
of the equilibrium potential could be widely utilized in other areas
of the nervous system to control local inhibitory strength.
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